| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Topiramate (PrevEp) | PrevEp-004 | Phase 2 Clinical | PrevEP Inc | Epilepsy, Benign Neonatal; Status Epilepticus | Details |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Brinzolamide/Timolol Maleate | Approved | Alcon | Azarga, Elazop | EU | Ocular Hypertension; Glaucoma, Open-Angle | Novartis Europharm Ltd | 2008-11-25 | Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension | Details | |
| Sultiame | Riker-594 | Approved | Desitin Arzneimittel Gmbh | Ospolot | Japan | Epilepsy | Kyowa Pharmaceutical Industry Co Ltd | 2001-12-01 | Epilepsy; Sleep Apnea, Obstructive | Details |
| Brinzolamide/Brimonidine Tartrate | Approved | Novartis Pharma Ag | Simbrinza | United States | Ocular Hypertension; Glaucoma, Open-Angle | Alcon Laboratories Inc | 2013-04-19 | Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension | Details | |
| Topiramate | SPN-538; KW-6485P; McN-4853; RWJ-17021; W-6485; TPM; USL-255 | Approved | Johnson & Johnson Innovative Medicine | 妥泰, Topamax, Topina, Conviban, Qudexy, Eprontia | United Kingdom | Migraine Disorders; Epilepsy | Johnson & Johnson Innovative Medicine | 1995-01-01 | Affective Disorders, Psychotic; Alcohol Drinking; Alcoholism; Binge-Eating Disorder; Bipolar Disorder; Brain Ischemia; Bulimia; Cocaine-Related Disorders; Cognition; Contraception; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Epilepsies, Partial; Epilepsy; Epilepsy, Absence; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Essential Tremor; Gambling; Headache; Heart Defects, Congenital; HIV Infections; Hyperlipidemias; Hypertension; Hypertriglyceridemia; Lennox Gastaut Syndrome; Lymphoma; Marijuana Abuse; Mental Disorders; Migraine Disorders; Migraine with Aura; Migraine without Aura; Mood Disorders; Obesity; Obesity, Morbid; Obsessive-Compulsive Disorder; Pain, Postoperative; Parkinson Disease; Pediatric Obesity; Peripheral Nervous System Diseases; Polyneuropathies; Sciatica; Seizures; Stress Disorders, Post-Traumatic; Tobacco Use Disorder; Tourette Syndrome; Vascular Headaches; Weight Loss | Details |
| Brinzolamide | AL-4862; ALO-4862 | Approved | Alcon | 派立明, Azopt | United States | Ocular Hypertension; Glaucoma, Open-Angle | Sandoz | 1998-04-01 | Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension | Details |